Answer:
D. all of the above
Explanation:
Australopithecus (first ape-man): Australopithecus is considered as the connecting link between apes and man as they shared the characteristics of both. The fossil records shows that they appeared around 5 million years ago. <em>Australopithecus africanus</em> was about 1.5 meters high and had human as well as ape like features. It was with bipedal locomotion, omnivorous in their diet and had erect posture. It had human like teeth with small canines and large chewing teeth. The brain was more like an ape with the brain capacity of about 500 cc similar to that of an ape. He lived in caves, had projected brow ridges with no chin. Its believed that <em>Australopithecus africanus</em> gave rise to <em>Homo habilis</em> about 2 million years ago.
The earliest species of Homo genus is <em>Homo habilis</em>. They were skill full man also called as handy man or the tool maker. He had erect posture with bipedal locomotion. The teeth were like modern man. He was skilled and made tools with stones. Slowly with evolution the prognathous face changed to orthognathous in cro magnon (<em>Homo sapiens fossilis</em>).
I think that the water concentration in the cell is more than the one in the solution, so the water in the cell moves to the solution and then the cell shrinks
The answer is Natural selection Hope it Helps
The phrase anatomical position is defined for human anatomy. It is body s<span>tanding upright, facing forward, arms at sides, palms forward, thumbs outward and toes forward.</span>
Answer:
A. Rifampicin is an example of an enzyme inhibiting drug, since it acts on the bacterial RNA polymerase, preventing the transcription and synthesis of proteins, so the bacteria is not viable and a human disease is controlled.
B. The drugs have specificity by microorganisms —target organisms— which are also smaller and more susceptible, while their effect is minimal or null in human cells and are not poisonous for them.
Explanation:
Bacteria, viruses, parasites and pathogenic fungi are microorganisms capable of producing disease in humans. One of the ways to fight infectious diseases is the use of drugs called antibiotics, capable of interfering with the development of microorganisms.
<u>Antibiotics or antibacterials are capable of preventing the synthesis of the bacterial wall or its reproduction, intervening in the synthesis of proteins</u>. They do this through enzymatic inhibition of these processes.
- Rifampicin is a drug capable of coupling itself to one of the sub-units of the RNA polymerase enzyme, changing its configuration and preventing its affinity for its substrate, the bacterial DNA. Rifampicin thus prevents the synthesis of proteins necessary for the development of the bacterium, which dies and thus manages to control an infectious disease.
- Drugs such as antibiotics act on specific bacterial functions —their target organism— by affecting the functions that allow them to live that allow them to live, as if they were poisoned. These same <u>drugs have little or no effect on human cells when administered in appropriate doses</u>. The few effects that are observed in human cells are not sufficient to kill them, but they do produce effects or secondary reactions, usually called adverse effects.
